Your browser doesn't support javascript.
loading
Identification of Monobenzone as a Novel Potential Anti-Acute Myeloid Leukaemia Agent That Inhibits RNR and Suppresses Tumour Growth in Mouse Xenograft Model.
Dong, Jingwen; Zhong, Tingting; Xu, Zhijian; Chen, Haiyi; Wang, Xianjun; Yang, Lili; Lou, Zhiyuan; Xu, Yuanling; Hou, Tingjun; Xu, Rongzhen; Zhu, Weiliang; Shao, Jimin.
Afiliação
  • Dong J; Department of Pathology and Pathophysiology, Cancer Institute of the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310005, China.
  • Zhong T; Key Laboratory of Disease Proteomics of Zhejiang Province, Key Laboratory of Cancer Prevention and Intervention of China National Ministry of Education, School of Medicine, Zhejiang University, Hangzhou 310030, China.
  • Xu Z; Cancer Center, Zhejiang University, Hangzhou 310030, China.
  • Chen H; Department of Pathology of Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou 310020, China.
  • Wang X; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 310063, China.
  • Yang L; Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310030, China.
  • Lou Z; Department of Pathology and Pathophysiology, Cancer Institute of the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310005, China.
  • Xu Y; Department of Pathology and Pathophysiology, Cancer Institute of the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310005, China.
  • Hou T; Department of Pathology and Pathophysiology, Cancer Institute of the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310005, China.
  • Xu R; Department of Pathology and Pathophysiology, Cancer Institute of the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310005, China.
  • Zhu W; Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310030, China.
  • Shao J; Department of Pathology and Pathophysiology, Cancer Institute of the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310005, China.
Cancers (Basel) ; 14(19)2022 Sep 27.
Article em En | MEDLINE | ID: mdl-36230632
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article